VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
56 hedge funds and large institutions have $17.8M invested in Viracta Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 10 closing their positions.
Holders
56
Holders Change
-2
Holders Change %
-3.45%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
13
Reduced
14
Closed
10
Calls
$65K
Puts
$6K
Net Calls
+$59K
Net Calls Change
-$333K
Top Buyers
Top Sellers
1 |
1
Goldman Sachs
New York
|
$0 |
2 |
2
BlackRock
New York
|
$654K |
3 |
MCM
3
MAI Capital Management
Independence,
Ohio
|
$623K |
4 |
E
4
Ergoteles
New York
|
$28.9K |
5 |
![]()
5
Franklin Resources
San Mateo,
California
|
$0 |